Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Gentiva Gets Alternative Offer After Kindred’s Hostile Bids

July 18 (Bloomberg) -- Gentiva Health Services Inc., the home health and hospice company resisting a hostile takeover attempt from Kindred Healthcare Inc., said it was approached by another investor in the sector with a higher bid.

The alternative bidder for Gentiva said it would offer $17.25 a share in cash. Based on Gentiva’s outstanding shares of about 36.8 million, the equity value of the deal would be $634.8 million. The company’s board said it would review this new proposal, without naming the bidder.

Gentiva rose 16 percent to $17.96 at 4 p.m. in New York trading, its highest price since July 2011 and giving it a market capitalization about $662 million.

Kindred offered this week to buy a 14.9 percent stake in Gentiva after the company rebuffed two takeover bids, a change in strategy to try to force the company to enter talks. That’s the most Kindred can buy without triggering a “poison pill” takeover defense as it seeks to force a deal with Gentiva.

Kindred’s current offer “significantly undervalues Gentiva’s shares, is coercive and not in the best interests of Gentiva stockholders,” said Atlanta-based Gentiva, while recommending that shareholders reject Kindred’s offer and not tender their shares.

A Kindred spokeswoman couldn’t be immediately reached for comment.

Kindred, a long-term medical care provider based in Louisville, Kentucky, would walk away if the new proposal isn’t successful in forcing talks, said Chief Executive Officer Paul Diaz in a July 14 statement. Gentiva also turned down a June offer from Kindred of $14.50 a share for the company, valued at $573 million, and an offer of $14 a share, or about $533 million, announced May 15.

To contact the reporter on this story: Sonali Basak in New York at sbasak7@bloomberg.net

To contact the editors responsible for this story: Reg Gale at rgale5@bloomberg.net Drew Armstrong

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.